Consensus or Controversy, Issue 3: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Hepatocellular Carcinoma
Submitted by web@researchtop... on Fri, 12/02/2011 - 11:00
 |
 |
|
 |
||
Consensus or Controversy, Issue 3: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Hepatocellular Carcinoma
Submitted by web@researchtop... on Thu, 12/01/2011 - 18:21
Consensus or Controversy, Issue 3: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Early HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by mphilemon@resea... on Wed, 11/23/2011 - 11:57
 |
|||||
 |
|||||
Consensus or Controversy, Issue 3: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Early HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by mphilemon@resea... on Wed, 11/23/2011 - 11:56
Email from the Editor
Click here to go directly to the web- and video-based education resources related to this week’s topic
Consensus or Controversy, Issue 3: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Early HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by web@researchtop... on Wed, 11/23/2011 - 11:29
Consensus or Controversy, Issue 3: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Early HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by web@researchtop... on Wed, 11/23/2011 - 11:07
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Metastatic HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by mphilemon@resea... on Mon, 11/21/2011 - 10:33
|
|||||
|
|||||
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Metastatic HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by web@researchtop... on Sat, 11/19/2011 - 13:41
Email from the Editor
Click here to go directly to the web- and video-based education resources related to this week’s topic
Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer
Submitted by web@researchtop... on Thu, 11/17/2011 - 09:39
|
|||||
|
|||||
Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer
Submitted by web@researchtop... on Wed, 11/16/2011 - 15:49
Email from the Editor
Click here to go directly to the web- and video-based education resources related to this week’s topic
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Metastatic HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by web@researchtop... on Tue, 11/15/2011 - 18:41
Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer
Submitted by web@researchtop... on Fri, 11/11/2011 - 12:29
Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer
Submitted by web@researchtop... on Fri, 11/11/2011 - 12:01
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Hepatic-Only Metastatic Colon Cancer
Submitted by web@researchtop... on Sat, 11/05/2011 - 15:36
Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Prostate Cancer
Submitted by web@researchtop... on Tue, 11/01/2011 - 15:40